Vault-13

5AM Venture Management, LLC

SAN FRANCISCO, CA · CIK 1799883 · 13F filing filed 2021-08-16

SEC-registered investment adviser since 2021 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
San Francisco, CA (main office)United States United Statesabout 8
Boston, MAUnited States United States7
New York, NYUnited States United States3

US visa salary filings

Job titleFilingsMedianRange
Senior Research AnalystNew York, NY 1 $350,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: 5AM Venture Management, LLC.

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$397.3m reported value -28.5% vs Q1 2021
12positions
98.1%in top 10
2 new 0 added 1 reduced 1 sold out vs Q1 2021

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 VOR BIOPHARMA INC COM COM 6,692,429 $124.8m31.41% 31.41% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 6.7m, Q2 2021 6.7m
2 AKOUOS INC COM COM 4,135,784 $51.9m13.06% 13.06% UnchangedShares held: Q3 2020 4.6m, Q4 2020 4.1m, Q1 2021 4.1m, Q2 2021 4.1m
3 IDEAYA BIOSCIENCES INC COM IDYA IDYA 1,798,066 $37.7m9.50% 9.50% UnchangedShares held: Q3 2020 3.5m, Q4 2020 1.8m, Q1 2021 1.8m, Q2 2021 1.8m
4 HOMOLOGY MEDICINES INC COM FIXX FIXX 4,535,919 $33.0m8.30% 8.30% UnchangedShares held: Q3 2020 5.5m, Q4 2020 4.5m, Q1 2021 4.5m, Q2 2021 4.5m
5 ARVINAS INC COM ARVN ARVN 400,000 $30.8m7.75% 7.75% ReducedShares held: Q3 2020 1.0m, Q4 2020 500.0k, Q1 2021 500.0k, Q2 2021 400.0k -100.0k -100,000 -20.0%
6 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 1,362,286 $25.7m6.46% 6.46% UnchangedShares held: Q3 2020 1.4m, Q4 2020 1.4m, Q1 2021 1.4m, Q2 2021 1.4m
7 CABALETTA BIO INC COM CABA CABA 2,984,263 $25.7m6.46% 6.46% UnchangedShares held: Q3 2020 3.7m, Q4 2020 3.4m, Q1 2021 3.0m, Q2 2021 3.0m
8 IMPEL NEUROPHARMA INC COM COM 2,884,791 $25.5m6.43% 6.43% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 2.9m
9 SCPHARMACEUTICALS INC COM SCPH SCPH 3,831,474 $23.4m5.89% 5.89% UnchangedShares held: Q3 2020 3.8m, Q4 2020 3.8m, Q1 2021 3.8m, Q2 2021 3.8m
10 JANUX THERAPEUTICS INC COM JANX JANX 446,266 $11.1m2.80% 2.80% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 446.3k
11 CIDARA THERAPEUTICS INC COM COM 2,006,511 $4.1m1.02% 1.02% UnchangedShares held: Q3 2020 2.0m, Q4 2020 2.0m, Q1 2021 2.0m, Q2 2021 2.0m
12 5 01 ACQUISITION CORP COM CL A COM CL A 365,126 $3.6m0.92% 0.92% UnchangedShares held: Q3 2020 0, Q4 2020 365.1k, Q1 2021 365.1k, Q2 2021 365.1k

Sold out since Q1 2021

SecurityTickerShares held beforeValue then
APREA THERAPEUTICS INC 619,157 $3.2m619.2k shares